scholarly journals When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

2020 ◽  
Vol Volume 15 ◽  
pp. 3375-3384
Author(s):  
Wen-Chien Cheng ◽  
Biing-Ru Wu ◽  
Wei-Chih Liao ◽  
Chih-Yu Chen ◽  
Wei-Chun Chen ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Clinically Important Deterioration ◽  
Deterioration Assessment

scholarly journals Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

2019 ◽  
Vol Volume 14 ◽  
pp. 531-546 ◽  
Author(s):  
Dave Singh ◽  
Leonardo M Fabbri ◽  
Stefano Vezzoli ◽  
Stefano Petruzzelli ◽  
Alberto Papi
Keyword(s):  
Triple Therapy ◽  
Clinically Important Deterioration

Clinically important deterioration in advanced COPD patients using single inhaler triple therapy: results from the FULFIL study

2017 ◽  
Author(s):  
Ian Naya ◽  
Helen Barnacle ◽  
Ruby Birk ◽  
Noushin Brealey ◽  
Maggie Tabberer ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Copd Patients ◽  
Clinically Important Deterioration

The key to successful eradication of H. pylori, using lansoprazole or rabeprazole based triple therapy, is clarithromycin resistance, not CYP2C19 polymorphism

2001 ◽  
Vol 120 (5) ◽  
pp. A587-A587
Author(s):  
I MIKI ◽  
N AOYAMA ◽  
T SAKAI ◽  
D SHIRASAKA ◽  
S EBARA ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Clarithromycin Resistance ◽  
Cyp2c19 Polymorphism ◽  
H Pylori

H pylori eradication with PPI-triple therapy in clinical practice: Factors of failure

2001 ◽  
Vol 120 (5) ◽  
pp. A584-A584
Author(s):  
J DELCHIER ◽  
F RUODOTTHORAVAL ◽  
A COURILLONMALLET ◽  
H LAMOULIATTE ◽  
J BRETAGNE ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Triple Therapy ◽  
H Pylori
Sign in / Sign up

Export Citation Format

Share Document